by healthadvances Posted on November 9, 2018April 13, 2020 Health Advances Presentation at ISPOR: An Initial Analysis of the Cost-Based Pricing Revisions in Japan Read More
by healthadvances Posted on November 9, 2018April 13, 2020 Health Advances Presentation at ISPOR: Findings from the First Five Years of the NICE HST Program for Ultra Rare Conditions Read More
by healthadvances Posted on November 9, 2015June 14, 2022 Beyond Turing and Valeant- Why is Drug Pricing Such a Hot Issue? Read More
by healthadvances Posted on June 25, 2015April 15, 2020 Drug Pricing & Reimbursement at the Boston CMO Network Read More
